диссертации / 23

68.Bailey S.M., Sarmandal P., Grant J.M. A comparison of three methods of

assessing inter-observer variation applied to measurement of the symphysisfundal height // Br J Obstet Gynaecol. – 1989 – Vol. 96 – №11 – P. 12661271.

69.Balcazar H., Haas J. Classification schemes of small-for-gestational age and type of intrauterine growth retardation and its implications to early neonatal mortality // Early Hum Dev. 1990. – Vol. 24 – №3 – P. 219-230.

70.Barker D.J.P. Fetal programming of coronary heart disease // Trends

Endocrinol Metab. – 2002 – Vol. 13 – №9 – P. 364–368.

71.Barnea E.R., Feldman D., Kaplan M., Morrish D.W. The dual effect of epidermal growth factor upon human chorionic gonadotropin secretion by the first trimester placenta in vitro // Journal of Clinical Endocrinology and Metabolism 1990. – Vol. 71 – P. 923–928.

72.Baschat A. Fetal responses to placental insufficiency: an update // BJOG –

2004 – Vol. 111 – №10 – P. 1031–1041.

73.Baschat A., Cosmi E., Bilardo C.M., Wolf H., Berg C., Rigano S., Germer U., Moyano D., Turan S., Hartung J., Bhide A., Müller T., Bower S., Nicolaides K.H., Thilaganathan B., Gembruch U., Ferrazzi E., Hecher K., Galan H.L., Harman C.R. Predictors of neonatal outcome in early-onset

placental dysfunction. // Obstet Gynecol – 2007. – Vol. 109 – №2 Pt 1 – P.

253–261.

74.Baschat A.A., Gembruch U., Harman C.R. The sequence of changes in

Doppler and biophysical parameters as severe fetal growth restriction

worsens // Ultrasound Obstet Gynecol – 2001 – Vol. 18 –№6 – P. 571-577.

75.Basel D, Lederer R, Diamant YZ. Longitudinal ultrasonic biometry of various parameters in fetuses with abnormal growth rate // Acta Obstet Gynecol Scand. – 1987 – Vol. 66 – №2 – P. 143-149.

76.Bastide A., Manning F., Harman C., Lange I., Morrison I. Ultrasound

evaluation of amniotic fluid: outcome of pregnancies with severe

151

oligohydramnios // Am J Obstet Gynecol. – 1986 – Vol. 154 – №4 – P. 895-

900.

77.Battaglia F.C., Lubchenco L.O. A practical classification of newborn infants

by weight and gestational age // J Pediatr – 1967. – Vol. 71 – №2 – P. 159-

163.

78.Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy // Nature Reviews. Drug Discovery – 2009. – Vol. 8 – P. 235– 253.

79.Beisher N.A. The Effect of maternal enemia upon the fetus // J Reprod Med.

– 1971. – Vol. 6 – P. 262-263.

80.Belizán J.M., Villar J., Nardin J.C., Malamud J., De Vicurna L.S. Diagnosis of intrauterine growth retardation by a simple clinical method: measurement of uterine height // Am J Obstet Gynecol. – 1978 – Vol. 131 – №6 – P. 643646.

81.Bernstein I.M., Horbar J.D., Badger G.J., Ohlsson A., Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction // The Vermont Oxford Network. Am J Obstet Gynecol – 2000. – Vol. 182 – P. 198–206.

82.Böttcher R.T., Niehrs C. Fibroblast growth factor signaling during early vertebrate development // Endocr. Rev. – 2005. – Vol. 26 – №1 – P. 63–77.

83.Branch D.W., Scott J.R., Kochenour N.K., Hershgold E. Obstetric complications associated with the lupus anticoagulant // N Engl J Med. – 1985. – Vol. 313 – №21 – P. 1322-1326.

84.Bujold E., Morency A.M., Roberge S., Lacasse Y., Forest J.C., Giguère Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis // J Obstet Gynaecol Can. – 2009 – Vol. 31 – №9 – P. 818-826.

152

85.Bukowski R., Uchida T., Smith G.C., Malone F.D., Ball R.H., Nyberg D.A., Comstock C.H., Hankins G.D., Berkowitz R.L., Gross S.J., Dugoff L., Craigo S.D., Timor I.E., Carr S.R., Wolfe H.M., D'Alton M.E. First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. Individualized norms of optimal fetal growth: fetal growth potential // Obstet Gynecol. – 2008 – Vol. 111 – №5 – P. 1065-1076.

86.Bukowski R., Burgett A.D., Gei A., Saade G.R., Hankins G.D. Impairment of fetal growth potential and neonatal encephalopthy // Am J Obstet Gynecol. – 2003. – Vol. 188 – №4 – P. 1011-1015.

87.Calvert J.P., Crean E.E., Newcombe R.G., Pearson J.F. Antenatal screening by measurement of symphysis-fundus height // Br Med J (Clin Res Ed). – 1982. – Vol. 285 – №6345 – P. 846-849.

88.Cambell S., Dewhurst C.J. Diagnosis of the small-for-dates fetus by serial ultrasonic cephalometry // Lancet – 1971. – Vol. 2 – P. 1002-1015.

89.Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele // Nature – 1996. – Vol. 380 – №6573 – P. 435–439.

90.Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions // Nat Med. – 2001. – Vol. 7 – №5 – P. 575–583.

91.Carrera JM. Intrauterine growth retardation // VIII World Congress of Gyneclogy and Obstetrics (FIGO), Mexico, October 1976.

92.Cellini C., Xu J., Arriaga A., Buchmiller-Crair T.L. Effect of epidermal growth factor infusion on fetal rabbit intrauterine growth retardation and small intestinal development // Journal of Pediatric Surgery. – 2004. – Vol. 39 – P. 891–897.

153

93.Chang C.H., Yu C.H., Chang F.M., Ko H.C., Chen H.Y. The assessment of normal fetal liver volume by three-dimensional ultrasound // Ultrasound Med Biol. – 2003. – Vol. 29 – №8 – P. 1123-1129.

94.Chang C.H., Yu C.H., Ko H.C., Chen C.L., Chang F.M. Fetal upper arm volume in predicting intrauterine growth restriction: a three-dimensional ultrasound study // Ultrasound Med Biol. – 2005. – Vol. 31 – №11 – P. 1435-1439.

95.Chang C.H., Yu C.H., Ko H.C., Chen C.L., Chang F.M. The efficacy assessment of thigh volume in predicting intrauterine fetal growth restriction by three-dimensional ultrasound // Ultrasound Med Biol. – 2005. – Vol. 31 –

№7 – P. 883-887.

96.Chang T.C., Robson S.C., Boys R.J., Spencer J.A. Prediction of the small for gestational age infant: which ultrasonic measurement is best? // Obstet Gynecol. – 1992. – Vol. 80 – №6 – P. 1030-1038.

97.Chang T.C., Robson S.C., Spencer J.A., Gallivan S. Identification of fetal growth retardation: comparison of Doppler waveform indices and serial ultrasound measurements of abdominal circumference and fetal weight // Obstet Gynecol. – 1993. – Vol. 82 – №2 – P. 230-236.

98.Chervenak F.A., Jeanty P., Hobbins J.C. Current status of fetal age and growth assessment // Clin Obstet Gynaecol. – 1983. – Vol. 10 – №3 – P. 423-444.

99.Clapp J.F. 3rd, McLaughlin M.K., Gellis J., Hemphill C., Catalano P.M. Regional distribution of cerebral blood flow in experimental intrauterine growth retardation // Am J Obstet Gynecol. – 1984. – Vol. 150 – №7 – P. 843-846.

100.Clark S.L. Patterns of intrauterine growth retardation // Clin Obstet Gynecol. – 1992. – Vol. 35 – P. 194-201.

101.Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal // Journal of Biological Chemistry – 1962 – Vol. 237 – P. 1555–1562.

154

102.Combs C.A., Jaekle R.K., Rosenn B., Pope M., Miodovnik M., Siddiqi T.A. Sonographic estimation of fetal weight based on a model of fetal volume // Obstet Gynecol. – 1993. – Vol. 82 – №3 – P. 365-370.

103.Combs CA, Jaekle RK, Rosenn B, Pope M, Miodovnik M, Siddiqi TA Sonographic estimation of fetal weight based on a model of fetal volume // Obstet Gynecol. – 1993. – Vol. 82 – №3 – P. 365-370.

104.Coumoul X., Deng C.X. Roles of FGF receptors in mammalian development and congenital diseases // Birth Defects Res C Embryo Today. – 2003. – Vol. 69 – №4 – P. 286-304.

105.Cunningham F.G., Cox S.M., Harstad T.W., Mason R.A., Pritchard J.A. Chronic renal disease and pregnancy outcome // Am J Obstet Gynecol. – 1990. – Vol. 163 – №2 – P. 453-459.

106.Dackor J., Strunk K.E., Wehmeyer M.M., Threadgill D.W. Altered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryos // Placenta – 2007. – Vol. 28 – P. 1211–1218.

107.Dashe JS, McIntire DD, Lucas MJ, Leveno KJ. Effects of symmetric and asymmetric fetal growth on pregnancy outcomes // Obstet Gynecol. – 2000.

– Vol. 96 – №3 – P. 321-327.

108.Derwig I., Lythgoe D.J., Barker G.J., Poon L., Gowland P., Yeung R., Zelaya F., Nicolaides K. Association of placental perfusion, as assessed by magnetic resonance imaging and uterine artery Doppler ultrasound, and its relationship to pregnancy outcome // Placenta. – 2013. – 4004 – №13 – P. 593-596.

109.Deutinger J., Bartil W., Pfersmann C., Neumark J., Bernaschek G., Fetal kidney volume and urine production in cases of fetal growth retardation // J. Perinat. Med. – 1987. – Vol. 15 – P. 307-315.

110.Divon MY, Haglund B, Nisell H, Otterblad PO, Westgren M. Fetal and neonatal mortality in the postterm pregnancy: the impact of gestational age

155

and fetal growth restriction // Am J Obstet Gynecol. – 1998. – Vol. 178 –

№4 – P. 726-731.

111.Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis // Am J Pathol. – 1995 – Vol. 146 – №5 – P. 1029-1039.

112.Espinoza J., Kusanovic J.P., Bahado-Singh R., Gervasi M.T., Romero R., Lee W., Vaisbuch E., Mazaki-Tovi S., Mittal P., Gotsch F., Erez O., Gomez R., Yeo L., Hassan S.S. Should bilateral uterine artery notching be used in the risk assessment for preeclampsia, small-for-gestational-age, and gestational hypertension? // J Ultrasound Med. – 2010. – Vol. 29 – №7 – P. 1103-1115.

113.F. Manning. OBJ Management. August 2000. 30-45.

114.Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O’Shea K.S., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene // Nature – 1996. – Vol. 380 – №6573 – P. 439–442.

115.Figueras F., Figueras J., Meler E., Eixarch E., Coll O., Gratacos E., Gardosi J., Carbonell X. Customised birthweight standards accurately predict perinatal morbidity // Arch Dis Child Fetal Neonatal Ed. – 2007. – Vol. 92 –

№4 – P. 277-280.

116.Fondacci C., Alsat E., Gabriel R., Blot P., Nessmann C., Evain-Brion D. Alterations of human placental epidermal growth factor receptor in intrauterine growth retardation // Journal of Clinical Investigation – 1994 – Vol. 93 – P. 1149–1155.

117.Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium // Nature – 1995. – Vol. 376 – №6535 – P. 66–70.

118.Forbes K., Westwood M. Maternal growth factor regulation of human placental development and fetal growth // J Endocrinol. – 2010. – Vol. 207 –

№1 – P. 1-16.

156

119.Froen J.F., Gardosi J.O., Thurmann A. et al. Restricted fetal growth in sadden intrauterine unexplained death // Acta Obstet Gynecol Scand. – 2004. – Vol. 83 – P. 801-807.

120.Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts // Lancet. – 1992. – Vol. 339 – №8788 – P. 283-287.

121.Garite T.J., Clark R., Thorp J.A. Intrauterine growth restriction increases morbidity and mortality among premature neonates // Am J Obstet Gynecol.

–2004. – Vol. 191 – №2 – P. 481-487.

122.Gascoin G., Flamant C. Long-term outcome in context of intra uterine growth restriction and/or small for gestational age newborns // J Gynecol Obstet Biol Reprod (Paris). – 2013. – Vol. 42 – №8 – P. 911-20.

123.Gelson E, Curry R, Gatzoulis MA, Swan L, Lupton M, Steer P, Johnson M. Effect of maternal heart disease on fetal growth // Obstet Gynecol. – 2011. – Vol. 117 – №4 – P. 886-891.

124.Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, Hintz RL, Rosenfeld RG. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth // J Clin Endocrinol Metab. – 1995. – Vol. 80 – №5 – P. 1548-1555.

125.Godfrey K.M., Barker D.J.P. Fetal nutrition and adult disease // Am J Clin Nutr. – 2000. – Vol. 71 (5 Suppl) – P. 1344-1352.

126.Gonzalez J.M., Stamilio D.M., Ural S., Macones G.A., Odibo A.O. Relationship between abnormal fetal testing and adverse perinatal outcomes in intrauterine growth restriction // Am J Obstet Gynecol. – 2007. – Vol. 196

–№5 – P. 48-51.

127.Grissa O., Yessoufou A., Mrisak I., Hichami A., Amoussou-Guenou D., Grissa A., Djrolo F., Moutairou K., Miled A., Khairi H. et al. Growth factorconcentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia //

157

Pregnancy and Childbirth. – 2010. – Vol. 10 – P.7.

128.Gruenwald P. Chronic fetal distress and placental insufficiency // Biol Neonate – 1963. – Vol. 5 – P. 215-221.

129.Gruenwald P. The relation of deprivation to perinatal pathology and late sequels // The Placenta. Lancaster – 1975.

130.Guzman E.R., Vintzileos A.M., Martins M., Benito C., Houlihan C., Hanley M. The efficacy of individual computer heart rate indices in detecting

acidemia at birth in growth-restricted fetuses // Obstet Gynecol. – 1996. – Vol. 87 – №6 – P. 969-974.

131. Habek D., Hodek B., Herman R., JugovićD ., Cerkez Habek J., SalihagićA.

Fetal biophysical profile and cerebro-umbilical ratio in assessment of perinatal outcome in growth-restricted fetuses // Fetal Diagn Ther. – 2003. – Vol. 18 – №1 – P. 12-16.

132.Hadlock F.P., Harrist R.B., Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard // Radiology. – 1991. – Vol. 181 –

№1 – P. 129-133.

133.Hadlock F.P., Harrist R.B., Sharman R.S., Deter R.L., Park S.K. Estimation of fetal weight with the use of head, body and femur measurements—a prospective study // Am J Obstet Gynecol. – 1985 – Vol. 151 – P. 333–337.

134.Harkness U.F., Mari G. Diagnosis and management of intrauterine growth restriction // Clin Perinatol. – 2004. – Vol. 31 – №4 – P.743-764.

135.Hediger M.L., Scholl T.O., Belsky D.H., Ances I. G., Salmon R.W. Patterns of weight gein in adolescent pregnancy: effects on bitht weight and preterm delivery // Obstet Gynecol. – 1989. – Vol. 74 – P. 6-12.

136.Henderson K.G., Shaw T.E., Barrett I.J., Telenius A.H., Wilson R.D., Kalousek D.K. Distribution of mosaicism in human placentae // Hum Genet.

– 1996. – Vol. 97 – №5 – P. 650-654.

137.Hendricks C.H. Patterns of fetal and placental growth: the second half of normal pregnancy // Obstet Gynecol. – 1964. – Vol. 24 – P. 357-365.

158

138.Hernandez-Valencia M., Zarate A., Ochoa R., Fonseca M.E., Amato D., De Jesus Ortiz M. Insulin-like growth factor I, epidermal growth factor and transforming growth factor b expression and their association with intrauterine fetal growth retardation, such as development during human pregnancy // Diabetes, Obesity and Metabolism. – 2001. – Vol. 3 – P. 457– 462.

139.Iyer S., Acharya K.R. Role of placenta growth factor in cardiovascular health // Trends Cardiovasc Med. – 2002. – Vol. 12 – P. 128–134.

140.Jahn A., Razum O., Berle P. Routine screening for intrauterine growth retardation in Germany: low sensitivity and questionable benefit for diagnosed cases // Acta Obstet Gynecol Scand. – 1998. – Vol. 77 – №6 – P. 643-648.

141.Jarvenpaa J., Vuoristo J.T., Savolainen E.R., Ukkola O., Vaskivuo T., Ryynanen M. Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction // Gynecol Endocrinol. – 2007. – Vol. 23 – №6 – P. 351–355.

142.Jelks A., Cifuentes R., Ross M.G. Clinician bias in fundal height measurement // Obstet Gynecol. – 2007. – Vol. 110 – №4 – P. 892-899.

143.Kahn B., Lumey L.H., Zybert P.A., et al. Prospective risk of fetal death in singleton, twin, and triplet gestations: Implications for practice // Obstet Gynecol. – 2003. – Vol. 102. – P. 685-692.

144.Kalousek D.K., Barrett I. Confined placental mosaicism and stillbirth // Pediatr Pathol. – 1994. – Vol. 14 – №1 – P. 151-159.

145.Kanaka-Gantenbein C., Mastorakos G., Chrousos G.P. Endocrine-related causes and consequences of intrauterine growth retardation // Ann N Y Acad Sci. – 2003. – Vol. 997 – P. 150–157.

146.Kaufmann P., Black S., Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia // Biol. Reprod. – 2003. – Vol. 69 – P. 1-7.

159

147.Kiess W., Chernausek S.D., Hokken-Koelega A.C.S. Small for Gestational Age: causes and consequences // Pediatr Adolesc Med. Basel: KARGER, 2009 (13); P. 167.

148.King J.C., Mitzner W., Butterfield A.B., Queenan J.T. Effect of induced oligohydramnios on fetal lung development // Am J Obstet Gynecol. – 1986.

–Vol. 154 – №4 – P. 823-830.

149.Klauwer D., Blum W.F., Rascher W., Lee P.D., Kiess W. IGF-I, IGF-II, free IGF-I and IGFBP-1, -2 and -3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newborns // Acta Paediatr.

–1997. – Vol. 86 – №8 – P. 826-833.

150.Kruger H., Arias-Stella J. The placenta and the newborn infant at high altitudes // Am J Obstet Gynecol. – 1970.

151.Kuizon M., Cheong R.L., Ancheta L.P., Desnacido J.A., Macapinlac M.P., Baens J.C. Effect of anemia and other maternal characteristics on birth weight // Hum Nutr Clin Nutr. – 1985. – Vol. 39 – P. 419-426.

152.Kupferminc M.J. Thrombophilia and pregnancy // Curr Pharm Des. – 2005.

–11 – №6 – P. 735-748.

153.Kupferminc M.J., Fait G., Many A., Gordon D., Eldor A., Lessing J.B. Severe preeclampsia and high frequency of genetic thrombophilic mutations // Obstet Gynecol. – 2000 – Vol. 96 – №1 – P. 45-49.

154.Kupferminc M.J., Many A., Bar-Am A., Lessing J.B., Ascher-Landsberg J. Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia // BJOG. – 2002 – Vol. 109 – №12 – P. 13731376.

155.Kurjak A., Chervenak F. A. Donald School Textbook of Ultrasound in Obstetrics and Gynecology. 3rd Edition – 2011.

156.Levi S., Kenwez J., Poor intrauterine fetal growth classification based on intauterine echography // Monerva Medica. – 1997. – P. 37-41.

160